Specifically, the elucidated interplay between KLF6, TAF6L and FOSL2, along with their regulatory influences on SEMA3C and the Wnt-β-catenin pathway, enhancing our understanding of the complex networks underlying cancer drug resistance. This evidence concerns the gene SEMA3C and cancer.